Skip to main content

Reactions Weekly

Ausgabe 1/2021

September 18, 2021

Inhalt (234 Artikel)

Case report

Abemaciclib

Case report

Adalimumab

Case report

Adalimumab/rifampicin

Case report

Adenosine

Case report

Alemtuzumab

Case report

Allopurinol/ibuprofen

Case report

Alteplase

Case report

Alteplase

Case report

Amiodarone/sotalol

Case report

Anastrozole

Case report

Antineoplastics

Case report

Antineoplastics

Case report

Antineoplastics

Case report

Antineoplastics

Case report

Antineoplastics

Case report

Antineoplastics

Case report

Antineoplastics

Case report

Antineoplastics

Case report

Asciminib

Case report

Aspirin

Case report

Aspirin/warfarin

Case report

Atorvastatin

Case report

Avatrombopag

Case report

Azd-1222

Case report

Azd-1222

Case report

Blinatumomab

Case report

Brentuximab-vedotin

Case report

Brolucizumab

Case report

Carboplatin/etoposide

Case report

Carvedilol

Case report

Cefazolin

Case report

Cefdinir/paracetamol

Case report

Cefepime/tazobactam

Case report

Cenegermin

Case report

Clopidogrel

Case report

Colchicine

Case report

Colchicine/prednisone

Case report

Cotrimoxazole

Case report

Cyanoacrylate

Case report

Dapagliflozin

Case report

Decitabine

Case report

Dexamethasone

Case report

Difluprednate

Case report

Dimethyl fumarate

Case report

Disulfiram

Case report

Doxazosin

Case report

Edoxaban/rivaroxaban

Case report

Eribulin

Case report

Erythromycin

Case report

Etoposide

Case report

Fentanyl

Case report

Ferric-carboxymaltose

Case report

Ferric-carboxymaltose

Case report

Fluoxetine

Case report

Gilteritinib

Case report

Gsk-137173a

Case report

Heparin

Case report

Heparin

Case report

Heparin

Case report

Heparin/nafamostat

Case report

Ibrutinib

Case report

Ibuprofen/naproxen

Case report

Idursulfase

Case report

Ifosfamide

Case report

Imatinib/chlorambucil

Case report

Immunosuppressants

Case report

Immunosuppressants

Case report

Infliximab

Case report

Ipilimumab/nivolumab

Case report

Ipilimumab/nivolumab

Case report

Isotretinoin

Case report

Ketamine

Case report

Ketamine abuse

Case report

Lanreotide/octreotide

Case report

Larotrectinib

Case report

Letrozole

Case report

Letrozole/Ribociclib

Case report

Linagliptin

Case report

Mercaptopurine

Case report

Metamfetamine abuse

Case report

Methotrexate

Case report

Methotrexate

Case report

Methylprednisolone

Case report

Micafungin/rifaximin

Case report

Midostaurin

Case report

Miltefosine

Case report

mRNA-1273

Case report

Multiple drug

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Mycophenolate-mofetil

Case report

Nitrofurantoin

Case report

Nivolumab

Case report

Nivolumab

Case report

Olanzapine

Case report

Olanzapine

Case report

Olaparib/rucaparib

Case report

Osilodrostat

Case report

Pantoprazole

Case report

Pazopanib

Case report

PEG-3350/pegaspargase

Case report

Pegaspargase

Case report

Pembrolizumab

Case report

Pembrolizumab

Case report

Ponatinib

Case report

Prednisolone

Case report

Prednisone

Case report

Ramucirumab

Case report

Remifentanil

Case report

Ribociclib

Case report

Ruxolitinib

Case report

Sevoflurane

Case report

Sorafenib

Case report

Sugammadex

Case report

Sunitinib

Case report

Sunitinib

Case report

Superoxide dismutase

Case report

Tagraxofusp

Case report

Temozolomide

Case report

Tretinoin

Case report

Tretinoin

Case report

Vancomycin

Case report

Venetoclax

Case report

Venetoclax